Filing Details
- Accession Number:
- 0001179110-12-013608
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-09-04 13:01:30
- Reporting Period:
- 2012-08-30
- Filing Date:
- 2012-09-04
- Accepted Time:
- 2012-09-04 13:01:30
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
882095 | Gilead Sciences Inc | GILD | Biological Products, (No Disgnostic Substances) (2836) | 943047598 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1327145 | L Robin Washington | Gilead Sciences, Inc. 333 Lakeside Drive Foster City CA 94404 | Svp, Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-08-30 | 3,466 | $57.48 | 11,413 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Pursuant to a Rule 105b-1 trading plan established by Ms. Washington on December 11, 2011.
- Sale prices reported for the transactions reported here range from $57.46 to $57.53. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.